Amgen Inc. buy BMO Capital Markets
Start price
03.12.25
/
50%
€288.65
Target price
03.12.26
-
Performance (%)
-2.93%
Price
22:26
€280.20
Summary
This prediction is currently active. With a performance of -2.93%, the BUY prediction for Amgen Inc. by BMO_Capital_Markets is down slightly. This prediction currently runs until 03.12.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Amgen Inc. | 0.519% |
| iShares Core DAX® | 0.224% |
| iShares Nasdaq 100 | 0.371% |
| iShares Nikkei 225® | 0.972% |
| iShares S&P 500 | 0.417% |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Ratings data for AMGN provided by MarketBeat